Zkušenosti s přípravou ⁶⁸Ga-PSMA-11

Warning

This publication doesn't include Faculty of Medicine. It includes Faculty of Pharmacy. Official publication website can be found on muni.cz.
Title in English Experience with the Preparation of Ga-68-PSMA-11
Authors

BUDINSKÝ Michal VYŠINSKÝ Petr ŘEHÁK Zdeněk ADAM Jan

Year of publication 2022
Type Article in Periodical
Magazine / Source CHEMICKÉ LISTY
MU Faculty or unit

Faculty of Pharmacy

Citation
Web http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/4167/4100
Doi http://dx.doi.org/10.54779/chl20220746
Keywords Ga-68-PSMA-11; prostate cancer; radiopharmacy; nuclear medicine
Description The radiopharmaceutical 68Ga-PSMA-11 represents a radiopharmaceutical drug without marketing authorization for the prostate cancer diagnosis in a specific treatment program. In respect of the radiopharmaceutical technology, the difficultness of the preparation of 68Ga-PSMA-11 is comparable to that of conventional radiopharmaceuticals.

You are running an old browser version. We recommend updating your browser to its latest version.

More info